ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 129 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $202,000 | -22.9% | 66,749 | 0.0% | 0.29% | -29.8% |
Q1 2018 | $262,000 | -5.1% | 66,749 | 0.0% | 0.41% | +122.8% |
Q4 2017 | $276,000 | -32.7% | 66,749 | 0.0% | 0.18% | -43.0% |
Q3 2017 | $410,000 | -1.2% | 66,749 | 0.0% | 0.32% | -1.5% |
Q2 2017 | $415,000 | -1.9% | 66,749 | 0.0% | 0.33% | -9.1% |
Q1 2017 | $423,000 | +18.5% | 66,749 | 0.0% | 0.36% | +36.2% |
Q4 2016 | $357,000 | -5.1% | 66,749 | 0.0% | 0.26% | -30.1% |
Q3 2016 | $376,000 | +2.7% | 66,749 | 0.0% | 0.38% | -0.3% |
Q2 2016 | $366,000 | -26.1% | 66,749 | 0.0% | 0.38% | -21.0% |
Q1 2016 | $495,000 | -29.6% | 66,749 | -21.1% | 0.48% | -19.7% |
Q4 2015 | $703,000 | -7.9% | 84,650 | 0.0% | 0.60% | +7.5% |
Q3 2015 | $763,000 | -24.9% | 84,650 | 0.0% | 0.56% | -4.6% |
Q2 2015 | $1,016,000 | – | 84,650 | – | 0.58% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |